短端粒与慢性淋巴细胞白血病不良预后、基因组复杂性及克隆演化相关
在CLL8试验(n=620)中全面分析端粒长度关联,并在CLL4试验(n=293)中验证。短端粒与不良预后因素和生存相关,17p-和11q-(分别伴TP53和ATM缺失)者端粒最短,即使亚克隆存在亦然。端粒缩短与基因组复杂性增加及克隆演化相关,可能先于高危异常获得。
要点
- 短端粒与CLL不良预后因素及生存相关。
- 17p-和11q-(伴TP53和ATM缺失)者端粒最短,亚克隆存在时亦然。
- 端粒缩短与基因组复杂性增加及克隆演化相关,可能先于高危异常。
核心结论
- 短端粒与CLL不良预后因素和生存相关,并与基因组复杂性增加及克隆演化相关,可能先于高危异常获得。
研究设计与样本
- 基于CLL8试验(n=620)的全面分析,并在CLL4试验代表性队列(n=293)中验证,采用定量PCR分析绝对端粒长度。
主要发现
- 短端粒长度与不良预后因素和生存相关。
- 17p-和11q-分别与TP53和ATM缺失相关,这些病例端粒最短,即使异常存在于小亚克隆中亦然。
- 端粒缩短与基因组复杂性增加及克隆演化相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Telomere length in chronic lymphocytic leukemia (CLL) has been shown to be of prognostic importance, but the analyses have largely been executed on heterogeneous patient cohorts outside of clinical trials. In the present study, we performed a comprehensive analysis of telomere length associations in the well characterized CLL8 trial (n = 620) of the German CLL study group, with validation in a representative cohort of the CLL4 trial (n = 293). Absolute telomere length was analyzed using quantitative-PCR. Apart from identifying associations of short telomere length with adverse prognostic factors and survival, the study identified cases with 17p- and 11q- associated with TP53 and ATM loss, respectively, to have the shortest telomeres, even when these aberrations were present in small subclones. Thus, telomere shortening may precede acquisition of the high-risk aberrations, contributing to disease evolution. In line with this, telomere shortening was associated with an increase in genomic complexity as well as clonal evolution, highlighting its importance as a biomarker especially in monitoring disease progression in non-high-risk CLL.
引用
- Jebaraj BMC, Tausch E, Landau DA, et al. Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia. Leukemia. 2019. PMID: 30911113. doi:10.1038/s41375-019-0446-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。